Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy
N Engl J Med. 2024 Jun 13;390(22):2047-2060. doi: 10.1056/NEJMoa2401361. ABSTRACT BACKGROUND: The risk of second tumors after chimeric antigen receptor (CAR) T-cell therapy, especially the …